Recursion Pharmaceuticals Inc (RXRX) has risen Wednesday morning, with the stock increasing 4.13% in pre-market trading to 7.31. RXRX's short-term technical score of 27 indicates that the stock has traded less bullishly over the last month than 73% of stocks on the market. In the Biotechnology industry, which ranks 128 out of 146 industries, Recursion Pharmaceuticals Inc ranks higher than 46% of stocks. Recursion Pharmaceuticals Inc has risen 32.95% over the past month, closing at $5.09 on November 1. During this period of time, the stock fell as low as $5.09 and as high as $7.77. RXRX has an average analyst recommendation of Buy. The company has an average price target of $15.29.
RXRX has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on RXRX!